|
Market Closed -
Other stock markets
|
Pre-market 01:32:09 am | |||
| 101.70 EUR | -3.00% |
|
101.60 | -0.10% |
| Feb. 16 | Capgemini in the red, as several brokers cut their target prices | |
| Feb. 16 | Bank of America Maintains Buy Rating on Capgemini, but Lowers Target Price |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.12 | 5.57 | 6.44 | 6.43 | 6.28 | |||||
Return on Total Capital | 7.42 | 8.19 | 9.54 | 9.39 | 9.04 | |||||
Return On Equity % | 13.14 | 15.88 | 17.01 | 16.5 | 15.06 | |||||
Return on Common Equity | 13.18 | 15.88 | 17.01 | 16.48 | 15.03 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 26.1 | 26.39 | 26.52 | 26.85 | 27.39 | |||||
SG&A Margin | 14.39 | 13.6 | 13.52 | 13.59 | 14.12 | |||||
EBITDA Margin % | 12.49 | 13.24 | 13.48 | 13.26 | 13.19 | |||||
EBITA Margin % | 11.5 | 12.32 | 12.51 | 12.33 | 12.29 | |||||
EBIT Margin % | 10.37 | 11.29 | 11.59 | 11.46 | 11.45 | |||||
Income From Continuing Operations Margin % | 6.03 | 6.38 | 7.05 | 7.41 | 7.59 | |||||
Net Income Margin % | 6.04 | 6.37 | 7.03 | 7.38 | 7.56 | |||||
Net Avail. For Common Margin % | 6.04 | 6.37 | 7.03 | 7.38 | 7.56 | |||||
Normalized Net Income Margin | 6 | 6.58 | 6.88 | 7 | 7.14 | |||||
Levered Free Cash Flow Margin | 7.22 | 12.79 | 9.08 | 9.69 | 9.45 | |||||
Unlevered Free Cash Flow Margin | 7.75 | 13.25 | 9.45 | 10.14 | 9.9 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.79 | 0.79 | 0.89 | 0.9 | 0.88 | |||||
Fixed Assets Turnover | 9.93 | 10.7 | 13.33 | 14.22 | 13.86 | |||||
Receivables Turnover (Average Receivables) | 4.44 | 4.36 | 4.58 | 4.47 | 4.41 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.31 | 1.38 | 1.28 | 1.34 | 1.21 | |||||
Quick Ratio | 1.17 | 1.24 | 1.16 | 1.24 | 1.09 | |||||
Operating Cash Flow to Current Liabilities | 0.28 | 0.4 | 0.31 | 0.35 | 0.33 | |||||
Days Sales Outstanding (Average Receivables) | 82.37 | 83.66 | 79.67 | 81.59 | 83.09 | |||||
Average Days Payable Outstanding | 36.84 | 38.73 | 37.71 | 35.99 | 36.26 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 147.93 | 90.16 | 77.49 | 62.99 | 51.68 | |||||
Total Debt / Total Capital | 59.67 | 47.41 | 43.66 | 38.65 | 34.07 | |||||
LT Debt/Equity | 127.69 | 85.91 | 63.54 | 54.15 | 42.15 | |||||
Long-Term Debt / Total Capital | 51.5 | 45.17 | 35.8 | 33.22 | 27.79 | |||||
Total Liabilities / Total Assets | 72.15 | 64.72 | 61.76 | 57.6 | 54.03 | |||||
EBIT / Interest Expense | 10.6 | 12.82 | 17.23 | 14.1 | 14.05 | |||||
EBITDA / Interest Expense | 14.79 | 17.02 | 22.08 | 17.93 | 17.84 | |||||
(EBITDA - Capex) / Interest Expense | 13.46 | 15.38 | 20.12 | 16.51 | 16.09 | |||||
Total Debt / EBITDA | 3.95 | 2.81 | 2.31 | 2.01 | 1.9 | |||||
Net Debt / EBITDA | 2.71 | 1.66 | 1.15 | 0.93 | 1.03 | |||||
Total Debt / (EBITDA - Capex) | 4.34 | 3.11 | 2.54 | 2.18 | 2.1 | |||||
Net Debt / (EBITDA - Capex) | 2.98 | 1.84 | 1.26 | 1.01 | 1.14 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 12.2 | 14.59 | 21.12 | 2.4 | -1.89 | |||||
Gross Profit, 1 Yr. Growth % | 7.4 | 15.86 | 21.7 | 3.7 | 0.07 | |||||
EBITDA, 1 Yr. Growth % | 9.7 | 21.46 | 23.71 | 0.74 | -2.38 | |||||
EBITA, 1 Yr. Growth % | 9.17 | 22.83 | 23.42 | 0.95 | -2.2 | |||||
EBIT, 1 Yr. Growth % | 6.83 | 24.83 | 24.88 | 1.22 | -2.01 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 12.09 | 21.36 | 33.74 | 7.61 | 0.54 | |||||
Net Income, 1 Yr. Growth % | 11.8 | 20.9 | 33.71 | 7.5 | 0.48 | |||||
Normalized Net Income, 1 Yr. Growth % | 2 | 25.59 | 27.24 | 4.25 | 0.02 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 11 | 20 | 31.98 | 6.6 | 1.07 | |||||
Accounts Receivable, 1 Yr. Growth % | 16.35 | 17.02 | 13.9 | -3.07 | 2.42 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 12.8 | 0.65 | -6.22 | -1.63 | 2.93 | |||||
Total Assets, 1 Yr. Growth % | 21.06 | 9.47 | 6.02 | -3.06 | 3.89 | |||||
Tangible Book Value, 1 Yr. Growth % | -4.2K | -33.87 | -28.4 | -31.38 | -9.76 | |||||
Common Equity, 1 Yr. Growth % | -27.55 | 38.74 | 14.88 | 7.47 | 12.64 | |||||
Cash From Operations, 1 Yr. Growth % | -7.41 | 55.39 | -2.48 | 0.32 | 0.04 | |||||
Capital Expenditures, 1 Yr. Growth % | 19.77 | 28.43 | 9.02 | -10.69 | 21.62 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -19.66 | 102.61 | -13.58 | 9.18 | -4.34 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -16.42 | 95.54 | -13.33 | 9.93 | -4.18 | |||||
Dividend Per Share, 1 Yr. Growth % | 44.44 | 23.08 | 35.42 | 4.62 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 9.58 | 13.39 | 17.81 | 11.36 | 0.23 | |||||
Gross Profit, 2 Yr. CAGR % | 7.64 | 11.55 | 18.75 | 12.34 | 1.87 | |||||
EBITDA, 2 Yr. CAGR % | 8.37 | 15.43 | 22.35 | 11.64 | -0.83 | |||||
EBITA, 2 Yr. CAGR % | 9.48 | 15.8 | 22.88 | 11.62 | -0.64 | |||||
EBIT, 2 Yr. CAGR % | 8.96 | 15.48 | 24.58 | 12.43 | -0.41 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 14.85 | 16.63 | 27.4 | 19.97 | 4.02 | |||||
Net Income, 2 Yr. CAGR % | 14.5 | 16.26 | 27.14 | 19.89 | 3.93 | |||||
Normalized Net Income, 2 Yr. CAGR % | 6.56 | 13.18 | 26.12 | 15.17 | 2.11 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 14.28 | 15.41 | 25.85 | 18.61 | 3.8 | |||||
Accounts Receivable, 2 Yr. CAGR % | 9.71 | 16.68 | 15.45 | 5.07 | -0.36 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 46.81 | 6.55 | -2.85 | -3.95 | 0.62 | |||||
Total Assets, 2 Yr. CAGR % | 15.36 | 15.12 | 7.73 | 1.38 | 0.35 | |||||
Tangible Book Value, 2 Yr. CAGR % | 171.94 | 420.44 | -31.19 | -29.91 | -21.31 | |||||
Common Equity, 2 Yr. CAGR % | -9.67 | 0.25 | 26.25 | 11.12 | 10.02 | |||||
Cash From Operations, 2 Yr. CAGR % | 9.08 | 19.95 | 23.1 | -1.09 | 0.18 | |||||
Capital Expenditures, 2 Yr. CAGR % | -6.57 | 23.42 | 19.23 | -1.32 | 4.22 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -1.53 | 27.7 | 32.05 | -2.86 | 2.2 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 0.57 | 27.95 | 29.92 | -2.39 | 2.63 | |||||
Dividend Per Share, 2 Yr. CAGR % | 7.1 | 33.33 | 29.1 | 19.02 | 2.28 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 8.16 | 11.23 | 15.91 | 12.43 | 6.76 | |||||
Gross Profit, 3 Yr. CAGR % | 6.92 | 10.31 | 14.84 | 13.5 | 8.09 | |||||
EBITDA, 3 Yr. CAGR % | 6.94 | 12.57 | 17.98 | 14.68 | 6.75 | |||||
EBITA, 3 Yr. CAGR % | 8.08 | 13.76 | 18.13 | 15.08 | 6.81 | |||||
EBIT, 3 Yr. CAGR % | 7.62 | 14.01 | 18.36 | 16.25 | 7.39 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 5.73 | 16.98 | 22.08 | 20.43 | 13.11 | |||||
Net Income, 3 Yr. CAGR % | 5.28 | 16.59 | 21.81 | 20.22 | 13.04 | |||||
Normalized Net Income, 3 Yr. CAGR % | 5.42 | 12.56 | 17.5 | 18.36 | 9.88 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 5.25 | 16.15 | 20.69 | 19.07 | 12.45 | |||||
Accounts Receivable, 3 Yr. CAGR % | 7.7 | 12.1 | 15.75 | 8.91 | 4.18 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 31.21 | 29.45 | 2.11 | -2.44 | -1.71 | |||||
Total Assets, 3 Yr. CAGR % | 11.25 | 13.36 | 12 | 4.01 | 2.21 | |||||
Tangible Book Value, 3 Yr. CAGR % | 105.15 | 69.74 | 168.67 | -31.25 | -23.75 | |||||
Common Equity, 3 Yr. CAGR % | -4.27 | 4.22 | 4.91 | 19.65 | 11.62 | |||||
Cash From Operations, 3 Yr. CAGR % | 7.69 | 22.73 | 11.95 | 14.98 | -0.72 | |||||
Capital Expenditures, 3 Yr. CAGR % | -5.1 | 3.55 | 19.02 | 8.28 | 5.8 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 9.29 | 25.31 | 11.96 | 23.94 | -3.36 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 10.62 | 25.59 | 12.22 | 22.89 | -2.99 | |||||
Dividend Per Share, 3 Yr. CAGR % | 4.68 | 12.18 | 34.02 | 20.36 | 12.31 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.87 | 7.69 | 11.92 | 11.28 | 9.36 | |||||
Gross Profit, 5 Yr. CAGR % | 6.09 | 7.38 | 11.5 | 11.12 | 9.46 | |||||
EBITDA, 5 Yr. CAGR % | 6.92 | 8.74 | 12.86 | 12.11 | 10.06 | |||||
EBITA, 5 Yr. CAGR % | 7.97 | 9.74 | 13.77 | 12.81 | 10.23 | |||||
EBIT, 5 Yr. CAGR % | 7.34 | 9.84 | 14.11 | 13.27 | 10.46 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -2.91 | 5 | 13.92 | 18.17 | 14.5 | |||||
Net Income, 5 Yr. CAGR % | -3.17 | 4.67 | 13.54 | 17.9 | 14.31 | |||||
Normalized Net Income, 5 Yr. CAGR % | 6.57 | 9.86 | 13.26 | 13.49 | 11.08 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -2.59 | 4.85 | 13.05 | 17.13 | 13.63 | |||||
Accounts Receivable, 5 Yr. CAGR % | 4.66 | 7.87 | 10.73 | 9.23 | 9.01 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 17.27 | 17.7 | 16.35 | 14.88 | 1.51 | |||||
Total Assets, 5 Yr. CAGR % | 6.18 | 7.87 | 9.83 | 8.41 | 7.19 | |||||
Tangible Book Value, 5 Yr. CAGR % | 36.37 | 34.61 | 32.53 | 19.16 | 64.4 | |||||
Common Equity, 5 Yr. CAGR % | -2.39 | 3.09 | 6.94 | 6.92 | 6.93 | |||||
Cash From Operations, 5 Yr. CAGR % | 10.59 | 14.37 | 13.61 | 12.58 | 7.08 | |||||
Capital Expenditures, 5 Yr. CAGR % | 0.8 | 5.87 | 3.77 | 1.88 | 12.86 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 14.44 | 22.51 | 17.92 | 13.08 | 7.95 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 14.57 | 22.07 | 18.01 | 13.46 | 8.28 | |||||
Dividend Per Share, 5 Yr. CAGR % | 7.63 | 9.14 | 13.84 | 14.87 | 20.29 |
- Stock Market
- Equities
- CAP Stock
- Financials Capgemini SE
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















